- Home
- TCS vs PMCB Comparison
TCS vs PMCB Comparison
Compare TCS & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCS
- PMCB
- Stock Information
- Founded
- TCS 1978
- PMCB 1996
- Country
- TCS United States
- PMCB United States
- Employees
- TCS N/A
- PMCB N/A
- Industry
- TCS Catalog/Specialty Distribution
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCS Consumer Discretionary
- PMCB Health Care
- Exchange
- TCS Nasdaq
- PMCB Nasdaq
- Market Cap
- TCS 14.3M
- PMCB 13.9M
- IPO Year
- TCS 2013
- PMCB N/A
- Fundamental
- Price
- TCS $2.80
- PMCB $1.69
- Analyst Decision
- TCS Hold
- PMCB
- Analyst Count
- TCS 1
- PMCB 0
- Target Price
- TCS $15.00
- PMCB N/A
- AVG Volume (30 Days)
- TCS 130.5K
- PMCB 14.9K
- Earning Date
- TCS 10-29-2024
- PMCB 12-13-2024
- Dividend Yield
- TCS N/A
- PMCB N/A
- EPS Growth
- TCS N/A
- PMCB N/A
- EPS
- TCS N/A
- PMCB 0.54
- Revenue
- TCS $799,372,000.00
- PMCB N/A
- Revenue This Year
- TCS N/A
- PMCB N/A
- Revenue Next Year
- TCS $2.37
- PMCB N/A
- P/E Ratio
- TCS N/A
- PMCB $3.27
- Revenue Growth
- TCS N/A
- PMCB N/A
- 52 Week Low
- TCS $1.79
- PMCB $1.39
- 52 Week High
- TCS $37.80
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- TCS 27.17
- PMCB 44.40
- Support Level
- TCS $1.79
- PMCB $1.59
- Resistance Level
- TCS $4.22
- PMCB $1.80
- Average True Range (ATR)
- TCS 0.51
- PMCB 0.16
- MACD
- TCS 0.03
- PMCB -0.01
- Stochastic Oscillator
- TCS 15.25
- PMCB 28.78
About TCS Container Store (The)
The Container Store Group Inc is a U.S. based specialty retailer of storage and organization products and solutions. It offers a collection of multifunctional and customizable storage and organization solutions. The company consists of two segments., The Container store segment consists of retail stores, website, and call center, as well as installation and organizational services business. The Elfa segment involves designing and manufacturing component-based shelving and drawer systems and made-to-measure sliding doors. It derives a majority of the revenue from the Container store segment.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.